Skip to main content
. 2022 Dec 12;12(12):1705. doi: 10.3390/brainsci12121705

Table 2.

Demographic and clinical characteristics of the participants.

CBS
(n = 14)
CBS-Non-AD
(n = 10)
CBS-AD
(n = 4)
CG
(n = 15)
CBS vs. CG
p-Value
CBS-Non-AD vs. CBS-AD vs. CG
p-Value
Age (y) 67.9 (8.4) 66.4 (8.3) 71.5 (8.7) 67.3 (8.1) 0.813 0.746
Education (y) 8.8 (5.8) 9.3 (5.9) 7.5 (6.0) 9.3 (5.4) 0.914 0.875
Sex (F/M) 9/5 5/5 4/0 10/5 0.892 0.203
Hand dominance (R/L) 12/2 8/2 4/0 14/1 0.500 0.430
Symptom duration (y) 4.6 (2.1) 4.7 (2.4) 4.5 (1.2) -- -- 0.770 *
CDR 1.9 (0.7) 1.9 (0.7) 2.0 (0.8) -- -- 0.941 *
FAQ 19.9 (7.8) 18.6 (7.6) 23.0 (8.4) -- -- 0.337 *
NPI 17.2 (16.7) 12.9 (8.7) 26.7 (27.1) -- -- 0.394 *
H&Y 2.9 (1.3) 3.0 (1.3) 2.7 (1.7) -- -- 0.774 *

Note: Comparison analyses across all groups were performed using ANOVA (normally distributed data) or the Kruskal–Wallis test (non-normal distribution). The CBS vs. CG and CBS-non-AD vs. CG were carried out using Student’s t-test (normal) or the Mann–Whitney test (non-normal). * CBS-non-AD vs. CBS-AD comparison using the t-test or the Mann–Whitney test. Sex and hand dominance were compared across groups using chi-squared test. Data are reported as the mean (SD). Abbreviations: CBS = corticobasal syndrome, CBS-non-AD = corticobasal syndrome not related to Alzheimer’s disease, CBS-AD = corticobasal syndrome related to Alzheimer’s disease; SD = standard deviation, y = years, CDR = Clinical Dementia Rating, FAQ = Functional Activities Questionnaire, NPI = Neuropsychiatric Inventory, and H&Y = Hoehn and Yahr scale.